Werewolf Therapeutics, Inc. (HOWL)
↓ Download CSVKey ratios (FY2025)
-245.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$60.68M | -$73.59M | -$40.50M | -$56.06M | -$50.09M | -$22.40M | — |
| Net Income | -$60.82M | -$70.52M | -$37.37M | -$53.81M | -$49.98M | -$15.04M | — |
| EPS (Diluted) | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 | — |
| Total Assets | $69.40M | $126.93M | $174.83M | $160.25M | $179.25M | $96.40M | — |
| Total Liabilities | $44.59M | $53.54M | $63.46M | $37.91M | $26.46M | $7.18M | — |
| Shareholders' Equity | $24.80M | $73.39M | $111.37M | $122.34M | $152.79M | -$51.86M | -$24.30M |
| Cash & Equivalents | $57.05M | $111.00M | $134.34M | $129.31M | $157.53M | $92.57M | — |
| Operating Cash Flow | -$60.29M | -$56.19M | -$32.61M | -$40.60M | -$42.88M | -$18.62M | — |
| Capital Expenditures | $0 | $254.0K | $769.0K | $3.61M | $498.0K | $560.0K | — |
| Shares Outstanding | 48.60M | 44.83M | 39.11M | 31.43M | 27.31M | 1.18M | — |